Compositions and methods for treating CNS disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 20, 2022
Grant Date -
Dec 17, 2020
app pub date -
Jan 21, 2020
filing date -
Oct 16, 2014
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance
Loading Importance Indicators...

Calculated Rating
US Family Size
|
Non-US Coverage
|
Abstract
Described herein are neuroactive steroids of the Formula (I):
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
- SAGE THERAPEUTICS, INC.
International Classification(s)

- 2020 Application Filing Year
- A61K Class
- 21530 Applications Filed
- 7999 Patents Issued To-Date
- 37.16 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Harrison, Boyd L | Princeton Junction, US | 126 | 1642 |
# of filed Patents : 126 Total Citations : 1642 | |||
Martinez, Botella Gabriel | Wayland, US | 132 | 1511 |
# of filed Patents : 132 Total Citations : 1511 | |||
Robichaud, Albert Jean | Boston, US | 146 | 1755 |
# of filed Patents : 146 Total Citations : 1755 | |||
Salituro, Francesco G | Marlborough, US | 216 | 2924 |
# of filed Patents : 216 Total Citations : 2924 |
Cited Art Landscape
- No Cited Art to Display
Loading Cited Art Landscape... 

Patent Citation Ranking
- 6 Citation Count
- A61K Class
- 81.11 % this patent is cited more than
- 3 Age
Forward Cite Landscape
- No Forward Cites to Display
Loading Forward Cite Landscape... 

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jun 20, 2026 |
7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jun 20, 2030 |
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 20, 2034 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text
US Patent Application No: 11530237
Compositions and methods for treating CNS disorders
Abstract
Described herein are neuroactive steroids of the Formula (I):
Description
Claims
Claims data not available

Legal Events
- No Legal Status data available.

Matter Detail

Country:
Application No:
Patent No:
Application Publication No:
Status:
Priority Date:
Filing Date:
Matter Type:
Local Registration No:
Docket No:
Secondary System Identifier (SSI):
Customer Application No:
Filing Type:
Request for Examination Date:
Parent Filing Date:
Complete Specification Date:
PCT Filing Date:
National Entry Date:
First Publication Date:
Allowance Date:
Grant Date:
Grant Publication Date:
Claims:
Independent Claims:
Law Firm:
Renewals Detail

Applicant:
Applicant ID:
Entity Size:
Renewal Status:
Renewal Base Date:
Renewal Trigger Date: